selenocysteine has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schomburg, L | 2 |
| An, JK; Chung, AS; Churchill, DG | 1 |
| Doskas, TK; Ntoskas, KT; Vavougios, GD | 1 |
2 review(s) available for selenocysteine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Selenoprotein P - Selenium transport protein, enzyme and biomarker of selenium status.
Topics: Animals; Biomarkers; Carrier Proteins; COVID-19; Humans; Mice; Peroxides; Selenium; Selenocysteine; Selenoprotein P | 2022 |
Nontoxic Levels of Se-Containing Compounds Increase Survival by Blocking Oxidative and Inflammatory Stresses via Signal Pathways Whereas High Levels of Se Induce Apoptosis.
Topics: Apoptosis; COVID-19; Humans; Oxidation-Reduction; Oxidative Stress; Selenium; Selenocysteine; Signal Transduction; Trace Elements | 2023 |
2 other study(ies) available for selenocysteine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Selenium Deficiency in COVID-19-A Possible Long-Lasting Toxic Relationship.
Topics: COVID-19; Humans; Nutritional Status; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Selenium; Selenocysteine; Selenoprotein P; Selenoproteins | 2022 |
Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients.
Topics: Blood Coagulation Disorders; Blood Platelets; COVID-19; Critical Illness; Endothelium, Vascular; Homeostasis; Humans; Immune System; Inflammation; Models, Theoretical; Oxidative Stress; Platelet Activation; SARS-CoV-2; Selenium; Selenocysteine; Transcriptome | 2021 |